l9n/ Mississippi

2020 Regular Session

House Bill 785

Pseudoephedrine and ephedrine; authorize sales and purchase of certain products containing without a prescription.

Did not become law. It stopped in the Senate's Judiciary, Division B Committee on June 9, 2020. The 2020 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO AUTHORIZE PHARMACIES TO SELL AND PERSONS TO PURCHASE, WITHOUT A PRESCRIPTION, PRODUCTS THAT CONTAIN CERTAIN QUANTITIES OF PSEUDOEPHEDRINE OR EPHEDRINE; TO REQUIRE PHARMACIES SELLING PRODUCTS AUTHORIZED UNDER THIS ACT TO USE THE NPLEX SYSTEM BEFORE SELLING THOSE PRODUCTS; TO REQUIRE PHARMACIES TO MAINTAIN AN ELECTRONIC LOG OF REQUIRED INFORMATION FOR EACH TRANSACTION; TO REQUIRE THE PURCHASER OF THE PACKAGE TO BE AT LEAST EIGHTEEN YEARS OF AGE, AS SHOWN BY VALID IDENTIFICATION, AND TO SIGN A RECORD OF EACH TRANSACTION; TO PROVIDE CRIMINAL PENALTIES FOR VIOLATIONS OF THIS ACT; TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO CONFORM TO THE PRECEDING PROVISIONS; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

Its course

February 13 to June 9, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action9 actions on 7 days

In the House of RepresentativesFeb 13 to Mar 1026 days

Drug PolicyFeb 13 to Feb 2613 days

In the SenateMar 10 to Jun 9 · stopped91 days

Drug PolicyMay 12 to Jun 423 days

Judiciary, Division BJun 4 to Jun 9 · stopped5 days

Amendments

Each amendment offered, and what became of it.

  • House of Representatives floor amendmentAdopted

    Adopted Mar 10

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the House of Representatives Feb 13 – Mar 10

  1. Feb 13Referred to the House committee on Drug Policy
  2. Feb 26Reported from committee in the House: title sufficient, do pass as a committee substitute
  3. Mar 10Committee substitute adopted in the House
  4. Amended in the House
  5. Passed the House as amended

In the Senate Mar 12 – Jun 9

  1. Mar 12Sent to the Senate
  2. May 12Referred to the Senate committees on Drug Policy and on Judiciary, Division B
  3. Jun 4Reported from DP to JB in the Senate: title sufficient, do pass
  4. Jun 9Died in committee in the Senate
All 9 actions, as published
  1. Feb 13Referred To Drug PolicyHouse of Representatives
  2. Feb 26Title Suff Do Pass Comm SubHouse of Representatives
  3. Mar 10Committee Substitute AdoptedHouse of Representatives
  4. Mar 10AmendedHouse of Representatives
  5. Mar 10Passed As AmendedHouse of Representatives
  6. Mar 12Transmitted To SenateHouse of Representatives
  7. May 12Referred To Drug Policy;Judiciary, Division BSenate
  8. Jun 4DR - TSDP: DP To JBSenate
  9. Jun 9Died In CommitteeSenate